Publication | Open Access
Characteristics and Reporting of Number Needed to Treat, Number Needed to Harm, and Absolute Risk Reduction in Controlled Clinical Trials, 2001-2019
23
Citations
6
References
2020
Year
Early Goals-of-care DiscussionsImportant LimitationsHarm ReductionCovid-19Preventive MedicineHealth CommunicationClinical TrialsRandomized Controlled TrialPatient-reported OutcomePublic HealthClinical EfficacyHealth Services ResearchDrug SafetyHealth PolicyPatient SupportCovid-19 PandemicClinical StudiesOutcomes ResearchEpidemiologyImplement ProgramsAbsolute Risk ReductionClinical EffectivenessNumber NeededControlled Clinical TrialsPatient SafetyPatient-centered OutcomeDrug TrialMedicineClinical Trial EvaluationClinical Trial Design
life. 7 Although there are important limitations on current data regarding outcomes of IHCA for patients with COVID-19, we have enough data to conclude that it is important to implement programs to promote conversations about values and goals in the community and early goals-of-care discussions for patients hospitalized with COVID-19.
| Year | Citations | |
|---|---|---|
Page 1
Page 1